{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:07:24Z","timestamp":1789679244277,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T00:00:00Z","timestamp":1701734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD09775"],"award-info":[{"award-number":["R01HD09775"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R21HD104412"],"award-info":[{"award-number":["R21HD104412"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["2T32HL105321"],"award-info":[{"award-number":["2T32HL105321"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F31DK130542"],"award-info":[{"award-number":["F31DK130542"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","award":["Pre-Doctoral Fellowship"],"award-info":[{"award-number":["Pre-Doctoral Fellowship"]}],"id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Utah College of Pharmacy","award":["Donald R. Gehlert Fellowship"],"award-info":[{"award-number":["Donald R. Gehlert Fellowship"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s00467-023-06199-z","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T10:01:54Z","timestamp":1701770514000},"page":"1521-1532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Medication patterns and dosing guidance in pediatric patients supported with intermittent hemodialysis or continuous kidney replacement therapy"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7985-2991","authenticated-orcid":false,"given":"Autumn M.","family":"McKnite","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle J.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raoul","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin M.","family":"Watt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,5]]},"reference":[{"key":"6199_CR1","doi-asserted-by":"publisher","first-page":"997","DOI":"10.2165\/00003088-200746120-00003","volume":"46","author":"F Pea","year":"2007","unstructured":"Pea F, Viale P, Pavan F, Furlanut M (2007) Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 46:997\u2013103. https:\/\/doi.org\/10.2165\/00003088-200746120-00003","journal-title":"Clin Pharmacokinet"},{"key":"6199_CR2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1525-139X.2011.00826.x","volume":"24","author":"L Awdishu","year":"2011","unstructured":"Awdishu L, Bouchard J (2011) How to optimize drug delivery in renal replacement therapy. Semin Dial 24:176\u2013182. https:\/\/doi.org\/10.1111\/j.1525-139X.2011.00826.x","journal-title":"Semin Dial"},{"key":"6199_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2215\/CJN.05630614","volume":"10","author":"TD Nolin","year":"2015","unstructured":"Nolin TD, Aronoff GR, Fissell WH, Jain L, Madabushi R, Reynolds K, Zhang L, Huang SM, Mehrotra R, Flessner MF, Leypoldt JK, Witcher JW, Zineh I, Archdeacon P, Roy-Chaudhury P, Goldstein SL; Kidney Health Initiative (2015) Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative. Clin J Am Soc of Nephrol 10:159\u2013164. https:\/\/doi.org\/10.2215\/CJN.05630614","journal-title":"Clin J Am Soc of Nephrol"},{"key":"6199_CR4","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2165\/00148581-200406010-00004","volume":"6","author":"MA Veltri","year":"2004","unstructured":"Veltri MA, Neu AM, Fivush BA, Parekh RS, Furth SL (2004) Drug dosing during intermittent hemodialysis and continuous renal replacement therapy: special considerations in pediatric patients. Paediatr Drugs 6:45\u201365. https:\/\/doi.org\/10.2165\/00148581-200406010-00004","journal-title":"Paediatr Drugs"},{"key":"6199_CR5","doi-asserted-by":"publisher","first-page":"e01306","DOI":"10.1128\/AAC.01306-18","volume":"62","author":"FB Sime","year":"2018","unstructured":"Sime FB, Pandey S, Karamujic N, Parker S, Alexander E, Loutit J, Durso S, Griffith D, Lipman J, Wallis SC, Roberts JA (2018) Ex vivo characterization of effects of renal replacement therapy modalities and settings on pharmacokinetics of meropenem and vaborbactam. Antimicrob Agents Chemother 62:e01306\u2013e01318. https:\/\/doi.org\/10.1128\/AAC.01306-18","journal-title":"Antimicrob Agents Chemother"},{"key":"6199_CR6","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/jcph.360","volume":"54","author":"EJ Nehus","year":"2014","unstructured":"Nehus EJ, Mouksassi S, Vinks AA, Goldstein S (2014) Meropenem in children receiving continuous renal replacement therapy: clinical trial simulations using realistic covariates. J Clin Pharmacol 54:1421\u20131428. https:\/\/doi.org\/10.1002\/jcph.360","journal-title":"J Clin Pharmacol"},{"key":"6199_CR7","first-page":"425","volume":"29","author":"S Morabito","year":"2012","unstructured":"Morabito S, Pistolesi V, Maggiore U, Fiaccadori E, Pierucci A (2012) Pharmacokinetics of antibiotics in continuous renal replacement therapies (CRRT). G Ital Nefrol 29:425\u2013444","journal-title":"G Ital Nefrol"},{"key":"6199_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/clpt.2014.102","volume":"96","author":"SL Goldstein","year":"2014","unstructured":"Goldstein SL, Nolin TD (2014) Lack of drug dosing guidelines for critically ill patients receiving continuous renal replacement therapy. Clin Pharmacol Ther 96:159\u2013161. https:\/\/doi.org\/10.1038\/clpt.2014.102","journal-title":"Clin Pharmacol Ther"},{"key":"6199_CR9","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1097\/PCC.0b013e31829f5bc8","volume":"14","author":"NA Rizkalla","year":"2013","unstructured":"Rizkalla NA, Feudtner C, Dai D, Zuppa AF (2013) Patterns of medication exposures in hospitalized pediatric patients with acute renal failure requiring intermittent or continuous hemodialysis. Pediatr Crit Care Med 14:e394\u2013e403. https:\/\/doi.org\/10.1097\/PCC.0b013e31829f5bc8","journal-title":"Pediatr Crit Care Med"},{"key":"6199_CR10","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/sdi.12203","volume":"27","author":"SJ Lewis","year":"2014","unstructured":"Lewis SJ, Mueller BA (2014) Antibiotic dosing in critically ill patients receiving CRRT: underdosing is overprevalent. Semin Dial 27:441\u2013445. https:\/\/doi.org\/10.1111\/sdi.12203","journal-title":"Semin Dial"},{"key":"6199_CR11","doi-asserted-by":"publisher","first-page":"101104","DOI":"10.1016\/j.imu.2022.101104","volume":"34","author":"AM McKnite","year":"2022","unstructured":"McKnite AM, Job KM, Nelson R, Sherwin CMT, Watt KM, Brewer SC (2022) Medication based machine learning to identify subpopulations of pediatric hemodialysis patients in an electronic health record database. Inform Unlocked 34:101104. https:\/\/doi.org\/10.1016\/j.imu.2022.101104","journal-title":"Inform Unlocked"},{"key":"6199_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4212\/cjhp.v63i2.898","volume":"63","author":"CM Mountford","year":"2010","unstructured":"Mountford CM, Lee T, de Lemos J, Loewen PS (2010) Quality and usability of common drug information databases. Can J Hosp Pharm 63:130\u2013137. https:\/\/doi.org\/10.4212\/cjhp.v63i2.898","journal-title":"Can J Hosp Pharm"},{"key":"6199_CR13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3390\/jcm9010110","volume":"9","author":"KH Lee","year":"2019","unstructured":"Lee KH, Sol IS, Park JT, Kim JH, Shin JW, Park MR, Lee JH, Kim YH, Kim KW, Shin JI (2019) Continuous renal replacement therapy (CRRT) in children and the specialized CRRT team: a 14-year single-center study. J Clin Med 9:110. https:\/\/doi.org\/10.3390\/jcm9010110","journal-title":"J Clin Med"},{"key":"6199_CR14","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1186\/s12882-018-1068-1","volume":"19","author":"AA Riley","year":"2018","unstructured":"Riley AA, Watson M, Smith C, Guffey D, Minard CG, Currier H, Akcan Arikan A (2018) Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation. BMC Nephrol 19:268. https:\/\/doi.org\/10.1186\/s12882-018-1068-1","journal-title":"BMC Nephrol"},{"key":"6199_CR15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jcrc.2008.12.017","volume":"24","author":"LW Hayes","year":"2009","unstructured":"Hayes LW, Oster RA, Tofil NM, Tolwani AJ (2009) Outcomes of critically ill children requiring continuous renal replacement therapy. J Crit Care 24:394\u2013400. https:\/\/doi.org\/10.1016\/j.jcrc.2008.12.017","journal-title":"J Crit Care"},{"key":"6199_CR16","unstructured":"Vaex Development Team (2022) What is Vaex? https:\/\/vaex.readthedocs.io\/. Accessed 12 Feb 2022"},{"key":"6199_CR17","unstructured":"R Core Team (2020) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. https:\/\/www.r-project.org\/. Accessed 12 Feb 2022"},{"key":"6199_CR18","unstructured":"Wickham H, Fran\u00e7ois R, Henry L, M\u00fcller K (2020) dplyr: A Grammar of Data Manipulation. R package version 1.0.2. https:\/\/CRAN.R-project.org\/package=dplyr. Accessed 12 Feb 2022"},{"key":"6199_CR19","unstructured":"Rich B (2021) Table1: tables of descriptive statistics in HTML. R package version 1.4.2. https:\/\/CRAN.R-project.org\/package=table1. Accessed 12 Feb 2022"},{"key":"6199_CR20","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1201\/9781315370279","volume-title":"Generalized Additive Models: An Introduction with R","author":"S Wood","year":"2017","unstructured":"Wood S (2017) Generalized Additive Models: An Introduction with R, 2nd edn. Chapman and Hall, Boca Raton, FL, p 496","edition":"2"},{"key":"6199_CR21","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00467-019-04213-x","volume":"35","author":"L de Galasso","year":"2020","unstructured":"de Galasso L, Picca S, Guzzo I (2020) Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol 35:753\u2013765. https:\/\/doi.org\/10.1007\/s00467-019-04213-x","journal-title":"Pediatr Nephrol"},{"key":"6199_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1055\/s-0035-1564736","volume":"5","author":"S Wang","year":"2016","unstructured":"Wang S (2016) Renal replacement therapy in the pediatric critical care unit. J Pediatr Intensive Care 5:59\u201363. https:\/\/doi.org\/10.1055\/s-0035-1564736","journal-title":"J Pediatr Intensive Care"},{"key":"6199_CR23","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1053\/j.ajkd.2019.10.010","volume":"75","author":"BR Griffin","year":"2020","unstructured":"Griffin BR, Liu KD, Teixeira JP (2020) Critical Care Nephrology: Core Curriculum 2020. Am J Kidney Dis 75:435\u2013452. https:\/\/doi.org\/10.1053\/j.ajkd.2019.10.010","journal-title":"Am J Kidney Dis"},{"key":"6199_CR24","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1097\/PCC.0000000000001047","volume":"18","author":"RS Watson","year":"2017","unstructured":"Watson RS, Crow SS, Hartman ME, Lacroix J, Odetola FO (2017) Epidemiology and outcomes of pediatric multiple organ dysfunction syndrome. Pediatr Crit Care Med 18:S4\u2013S16. https:\/\/doi.org\/10.1097\/PCC.0000000000001047","journal-title":"Pediatr Crit Care Med"},{"key":"6199_CR25","doi-asserted-by":"publisher","first-page":"732","DOI":"10.2215\/CJN.03200906","volume":"2","author":"JM Symons","year":"2007","unstructured":"Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein L (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732\u2013738. https:\/\/doi.org\/10.2215\/CJN.03200906","journal-title":"Clin J Am Soc Nephrol"},{"key":"6199_CR26","doi-asserted-by":"publisher","first-page":"260","DOI":"10.5144\/0256-4947.2018.260","volume":"38","author":"T Al-Ayed","year":"2018","unstructured":"Al-Ayed T, Rahman NU, Alturki A, Aljofan F (2018) Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study. Ann Saudi Med 38:260\u2013268. https:\/\/doi.org\/10.5144\/0256-4947.2018.260","journal-title":"Ann Saudi Med"},{"key":"6199_CR27","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jpeds.2012.08.044","volume":"162","author":"DJ Askenazi","year":"2013","unstructured":"Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children \u226410 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162:587-592.e3. https:\/\/doi.org\/10.1016\/j.jpeds.2012.08.044","journal-title":"J Pediatr"},{"key":"6199_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4103\/1319-2442.279961","volume":"31","author":"F Aygun","year":"2020","unstructured":"Aygun F (2020) Evaluation of continuous renal replacement therapy and risk factors in the pediatric intensive care unit. Saudi J Kidney Dis Transpl 31:53\u201361. https:\/\/doi.org\/10.4103\/1319-2442.279961","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"6199_CR29","unstructured":"Ramzy M, McAllister RK (2022) Vecuronium. In StatPearls. Treasure Island (FL): StatPearls. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK493143\/. Accessed 16 Feb 2023"},{"key":"6199_CR30","unstructured":"Dalal R, Grujic D (2023) Epinephrine. In StatPearls. Treasure Island (FL): StatPearls. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482160. Accessed 16 Feb 2023"},{"key":"6199_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40560-018-0330-8","volume":"6","author":"W Chaijamorn","year":"2018","unstructured":"Chaijamorn W, Charoensareerat T, Srisawat N, Pattharachayakul S, Boonpeng A (2018) Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study. J Intensive Care 6:61. https:\/\/doi.org\/10.1186\/s40560-018-0330-8","journal-title":"J Intensive Care"},{"key":"6199_CR32","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2215\/CJN.04330418","volume":"14","author":"AD Sinha","year":"2019","unstructured":"Sinha AD, Agarwal R (2019) Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD. Clin J Am Soc Nephrol 14:757\u2013764. https:\/\/doi.org\/10.2215\/CJN.04330418","journal-title":"Clin J Am Soc of Nephrol"},{"key":"6199_CR33","unstructured":"Herman LL, Bashir K (2022) Hydrochlorothiazide. In StatPearls. Treasure Island (FL): StatPearls. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK430766\/. Accessed 16 Feb 2023"},{"key":"6199_CR34","unstructured":"Ghiasi N, Bhansali RK, Marwaha R (2023) Lorazepam. In StatPearls. Treasure Island (FL): StatPearls. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532890\/. Accessed 16 Feb 2023"},{"key":"6199_CR35","doi-asserted-by":"publisher","first-page":"e89072","DOI":"10.1371\/journal.pone.0089072","volume":"9","author":"Y Ingrasciotta","year":"2014","unstructured":"Ingrasciotta Y, Sultana J, Giorgianni F, Caputi AP, Arcoraci V, Tari DU, Linguiti C, Perrotta M, Nucita A, Pellegrini F, Fontana A, Cavagna L, Santoro D, Trifir\u00f2 G (2014) The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy. PLoS One 9:e89072. https:\/\/doi.org\/10.1371\/journal.pone.0089072","journal-title":"PLoS ONE"},{"key":"6199_CR36","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1093\/ckj\/sfab210","volume":"15","author":"A Bosi","year":"2021","unstructured":"Bosi A, Xu Y, Gasparini A, Wettermark B, Barany P, Bellocco R, Inker LA, Chang AR, McAdams-DeMarco M, Grams ME, Shin JI, Carrero JJ (2021) Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care. Clin Kidney J 15:442\u2013451. https:\/\/doi.org\/10.1093\/ckj\/sfab210","journal-title":"Clin Kidney J"},{"key":"6199_CR37","doi-asserted-by":"publisher","first-page":"205435812211496","DOI":"10.1177\/20543581221149621","volume":"10","author":"MJ Armstrong","year":"2023","unstructured":"Armstrong MJ, Zhang K, Ye F, Klarenbach SW, Pannu NI (2023) Population-based analysis of nonsteroidal anti-inflammatory drug prescription in subjects with chronic kidney disease. Can J Kidney Health Dis 10:20543581221149620. https:\/\/doi.org\/10.1177\/20543581221149621","journal-title":"Can J Kidney Health Dis"},{"key":"6199_CR38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.2215\/CJN.0355031","volume":"15","author":"CE Lefebvre","year":"2020","unstructured":"Lefebvre CE, Filion KB, Reynier P, Platt RW, Zappitelli M (2020) Primary care prescriptions of potentially nephrotoxic medications in children with CKD. Clin J Am Soc Nephrol 15:61\u201368. https:\/\/doi.org\/10.2215\/CJN.0355031","journal-title":"Clin J Am Soc Nephrol"},{"key":"6199_CR39","doi-asserted-by":"publisher","first-page":"e218","DOI":"10.1097\/PCC.000000000000068","volume":"17","author":"D Dai","year":"2016","unstructured":"Dai D, Feinstein JA, Morrison W, Zuppa AF, Feudtner C (2016) Epidemiology of polypharmacy and potential drug-drug interactions among pediatric patients in ICUs of U.S. Children\u2019s Hospitals. Pediatr Crit Care Med 17:e218\u2013e228. https:\/\/doi.org\/10.1097\/PCC.000000000000068","journal-title":"Children's Hospitals Pediatr Crit Care Med"},{"key":"6199_CR40","doi-asserted-by":"publisher","first-page":"555407","DOI":"10.3389\/fphar.2020.555407","volume":"11","author":"EDC Lima","year":"2020","unstructured":"Lima EDC, Camarinha BD, Ferreira Bezerra NC, Panisset AG, Belmino de Souza R, Silva MT, Lopes LC (2020) Severe potential drug-drug interactions and the increased length of stay of children in intensive care unit. Front Pharmacol 11:555407. https:\/\/doi.org\/10.3389\/fphar.2020.555407","journal-title":"Front Pharmacol"},{"key":"6199_CR41","doi-asserted-by":"publisher","first-page":"e0246754","DOI":"10.1371\/journal.pone.0246754","volume":"16","author":"YH Choi","year":"2021","unstructured":"Choi YH, Lee IH, Yang M, Cho YS, Jo YH, Bae HJ, Kim YS, Park JD (2021) Clinical significance of potential drug-drug interactions in a pediatric intensive care unit: A single-center retrospective study. PLoS One 16:e0246754. https:\/\/doi.org\/10.1371\/journal.pone.0246754","journal-title":"PLoS ONE"},{"key":"6199_CR42","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1093\/cid\/ciaa224","volume":"72","author":"JA Roberts","year":"2021","unstructured":"Roberts JA, Joynt GM, Lee A, SMARRT Study Collaborators and the ANZICS Clinical Trials Group et al (2021) The Effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: data from the multinational sampling antibiotics in renal replacement therapy study. Clin Infect Dis 72:1369\u20131378. https:\/\/doi.org\/10.1093\/cid\/ciaa224","journal-title":"Clin Infect Dis"},{"key":"6199_CR43","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.2165\/00003088-200645100-00005","volume":"45","author":"AN Edginton","year":"2006","unstructured":"Edginton AN, Schmitt W, Willmann S (2006) Development and evaluation of a generic physiologically based pharmacokinetic model for children. Clin Pharmacokinet 45:1013\u20131034. https:\/\/doi.org\/10.2165\/00003088-200645100-00005","journal-title":"Clin Pharmacokinet"},{"key":"6199_CR44","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1002\/psp4.12338","volume":"7","author":"KM Watt","year":"2018","unstructured":"Watt KM, Cohen-Wolkowiez M, Barrett JS, Sevestre M, Zhao P, Brouwer KLR, Edginton AN (2018) Physiologically based pharmacokinetic approach to determine dosing on extracorporeal life support: fluconazole in children on ECMO. CPT Pharmacometrics Syst Pharmacol 7:629\u2013637. https:\/\/doi.org\/10.1002\/psp4.12338","journal-title":"CPT Pharmacometrics Syst Pharmacol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-023-06199-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-023-06199-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T13:06:45Z","timestamp":1710767205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-023-06199-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["6199"],"URL":"https:\/\/doi.org\/10.1007\/s00467-023-06199-z","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,5]]},"assertion":[{"value":"9 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}